Can a ‘miracle’ weight loss drug end Britain's obesity epidemic? [Replay]

This podcast delves into the effects of Ozempic and Wegovy, weight-loss medications originally designed for diabetes, on the obesity crisis in Britain. Produced by Novo Nordisk, these drugs have surged in popularity due to their impressive weight-loss results, resulting in shortages and raising ethical questions about their off-label use. Although the NHS has started prescribing Wegovy for weight loss in specific situations, experts caution that these medications are not quick fixes; they require accompanying lifestyle changes for lasting results. The conversation also highlights Novo Nordisk's fascinating history and examines the wider societal issues contributing to the obesity epidemic in Britain.